Editorial support for the final version of this article, comprising of language editing, content checking, formatting, and referencing was provided by Sophie Rushton-Smith, Ph.D. Dr Boonen is senior clinical investigator of the
Fund for Scientific Research, Flanders, Belgium (F.W.O.-Vlaanderen) and BVD-523 cost holder of the Leuven University Chair in Metabolic Bone Diseases. Funding GLOW is sponsored by a grant from The Alliance for Better Bone Health (Procter & Gamble Pharmaceuticals XAV-939 datasheet and sanofi-aventis). Conflicts of interest Ethel S Siris—consulting fees: Amgen, Lilly, Merck, Procter & Gamble, sanofi-aventis, Novartis. Stephen Gehlbach—research and salary support: The Alliance for Better Bone Health (Procter & Gamble Pharmaceuticals, sanofi-aventis). Jonathan D Adachi—research Sepantronium solubility dmso and salary support: Amgen, Astra Zeneca, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Nycomed, Pfizer, Procter & Gamble, Roche, sanofi-aventis, Servier, Wyeth, Bristol-Myers Squibb; clinical trials: Amgen, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Procter & Gamble, Roche, sanofi-aventis, Wyeth, Bristol-Myers Squibb. Steven Boonen—research grants: Amgen, Eli Lilly, Novartis, Pfizer, Procter & Gamble, sanofi-aventis, Roche, GlaxoSmithKline; Speakers’ bureau:
Amgen, Eli Lilly, Merck, Novartis, Procter & Gamble, sanofi-aventis, Servier; honoraria: Amgen, Eli Lilly, Merck, Novartis, Procter & Gamble, sanofi-aventis, Servier; consultant/advisory board: Amgen, Eli Lilly, Merck, Novartis, Procter & Gamble, sanofi-aventis, Servier. Roland Chapurlat—research grants: French Ministry of Health, Servier, Lilly, Procter & Gamble; honoraria from Servier, Novartis, Lilly, Roche, sanofi-aventis, Maxence Pharma; consultant/advisory board: Servier, Nycomed, Novartis, Maxence Pharma. Juliet Compston—consultancy: Servier, Shire, Nycomed, Novartis, Amgen, Procter & Gamble, Wyeth, Pfizer, The Alliance much for Better Bone Health, Roche, GlaxoSmithKline; speaking engagements (with reimbursement, travel and accommodation): Servier, Procter & Gamble, Eli
Lilly; research grants: Servier R&D, Procter & Gamble. Cyrus Cooper—consultancy and lecturing: Amgen, The Alliance for Better Bone Health, Eli Lily, Merck Sharp and Dohme, Servier, Novartis, Roche-GSK. Pierre Delmas: None. Adolfo Díez-Pérez—honoraria: Novartis, Eli Lilly, Amgen, Procter & Gamble, Roche; Expert witness for Merck—consultant/advisory board: Novartis, Eli Lilly, Amgen, Procter & Gamble; research and salary support: Novartis, Eli Lilly, Amgen, Procter & Gamble, Roche. Frederick H Hooven—research and salary support: The Alliance for Better Bone Health (Procter & Gamble Pharmaceuticals, sanofi-aventis). Andrea LaCroix—research and salary support: The Alliance for Better Bone Health (Procter & Gamble Pharmaceuticals and sanofi-aventis).